New Delhi, Delhi
GST No. 07ABSFM4621N2ZN
Call 08047305391 71% Response Rate
Product Brochure
Packaging Size | 30 TAB |
Medicine Type | Allopathic |
Brand | ALL BRANDS |
Composition | CABOZANTINIB |
Manufacturer | ALL COMPANY |
Treatment | renal cell carcinoma(KIDNEY CANCER) |
Prescription/Non prescription | Prescription |
Form | TABLET |
Usage | renal cell carcinoma(KIDNEY CANCER) |
Cabozantinib (Cabometyx, Cometriq) is used to treat a number of conditions.
Cabozantinib (Cabometyx) is used:Cabozantinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
How should this medicine be used?Cabozantinib comes as a tablet (Cabometyx) and a capsule (Cometriq) to take by mouth. It is usually taken once a day on an empty stomach, at least 1 hour before and 2 hours after eating. Take cabozantinib at around the same time every day. The length of your treatment depends on how well your body responds to the medication and the side effects that you experience. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take cabozantinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the tablets and capsules whole with a full glass (8 ounces, 240 mL) of water. Do not split, chew, crush, or open them.
Your doctor may decrease your dose of cabozantinib or permanently or temporarily stop your treatment if you experience serious side effects. Be sure to talk to your doctor about how you are feeling during your treatment with cabozantinib.
Additional Information:
View Complete details
Product Brochure
Packaging Size | 30'S TAB BOTT |
Composition | Dolutegravir and Tenofovir disoproxil fumarate |
Treatment | HIV (human immunodeficiency virus) infection. |
Prescription/Non prescription | Prescription |
Form | Tablet |
Country of Origin | Made in India |
Additional Information:
View Complete details